291 related articles for article (PubMed ID: 10084467)
1. Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge.
Giannini D; Bacci E; Dente FL; Di Franco A; Vagaggini B; Testi R; Paggiaro P
Chest; 1999 Mar; 115(3):629-34. PubMed ID: 10084467
[TBL] [Abstract][Full Text] [Related]
2. Tolerance to the protective effect of salmeterol on allergen challenge can be partially restored by the withdrawal of salmeterol regular treatment.
Giannini D; Di Franco A; Bacci E; Dente FL; Bartoli ML; Vagaggini B; Paggiaro P
Chest; 2001 Jun; 119(6):1671-5. PubMed ID: 11399689
[TBL] [Abstract][Full Text] [Related]
3. Minimal tolerance to the bronchoprotective effect of inhaled salmeterol/fluticasone combination on allergene challenge.
Paggiaro PL; Giannini D; Di Franco A; Bacci E; Dente FL; Vagaggini B; Tonelli M; Zingoni M
Pulm Pharmacol Ther; 2006; 19(6):425-9. PubMed ID: 16326121
[TBL] [Abstract][Full Text] [Related]
4. Tolerance to the protective effect of salmeterol in mild untreated asthmatics.
Giannini D; Di Franco A; Bacci E; Dente FL; Vagaggini B; Taccola M; Tonelli M; Zingoni M; Paggiaro P
Pulm Pharmacol Ther; 2003; 16(6):355-60. PubMed ID: 14580927
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
Kalra S; Swystun VA; Bhagat R; Cockcroft DW
Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
[TBL] [Abstract][Full Text] [Related]
6. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses.
Pizzichini MM; Kidney JC; Wong BJ; Morris MM; Efthimiadis A; Dolovich J; Hargreave FE
Eur Respir J; 1996 Mar; 9(3):449-55. PubMed ID: 8730003
[TBL] [Abstract][Full Text] [Related]
7. Tolerance to the protective effect of salmeterol on allergen challenge.
Giannini D; Carletti A; Dente FL; Bacci E; Di Franco A; Vagaggini B; Paggiaro PL
Chest; 1996 Dec; 110(6):1452-7. PubMed ID: 8989060
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.
Simons FE; Gerstner TV; Cheang MS
Pediatrics; 1997 May; 99(5):655-9. PubMed ID: 9113940
[TBL] [Abstract][Full Text] [Related]
9. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.
Pinto Pereira LM; Clement Y; Rouse J; Matthew J; Asgarali Z; Ramoutar D; Teelucksingh S
Int J Clin Pharmacol Res; 2003; 23(2-3):69-74. PubMed ID: 15025036
[TBL] [Abstract][Full Text] [Related]
10. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.
Turner MO; Johnston PR; Pizzichini E; Pizzichini MM; Hussack PA; Hargreave FE
Can Respir J; 1998; 5(4):261-8. PubMed ID: 9753527
[TBL] [Abstract][Full Text] [Related]
12. Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics.
Nielsen LP; Pedersen B; Faurschou P; Madsen F; Wilcke JT; Dahl R
Respir Med; 1999 Dec; 93(12):863-8. PubMed ID: 10653047
[TBL] [Abstract][Full Text] [Related]
13. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
Lipworth BJ; Aziz I
J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
[TBL] [Abstract][Full Text] [Related]
14. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group.
Greening AP; Ind PW; Northfield M; Shaw G
Lancet; 1994 Jul; 344(8917):219-24. PubMed ID: 7913155
[TBL] [Abstract][Full Text] [Related]
15. Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients.
Yates DH; Kharitonov SA; Barnes PJ
Eur Respir J; 1997 Jul; 10(7):1483-8. PubMed ID: 9230234
[TBL] [Abstract][Full Text] [Related]
16. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
Woolcock A; Lundback B; Ringdal N; Jacques LA
Am J Respir Crit Care Med; 1996 May; 153(5):1481-8. PubMed ID: 8630590
[TBL] [Abstract][Full Text] [Related]
17. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
Simons FE
N Engl J Med; 1997 Dec; 337(23):1659-65. PubMed ID: 9385125
[TBL] [Abstract][Full Text] [Related]
18. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
Yates DH; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
[TBL] [Abstract][Full Text] [Related]
19. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
20. A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma.
Nathan RA; Pinnas JL; Schwartz HJ; Grossman J; Yancey SW; Emmett AH; Rickard KA
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):521-9. PubMed ID: 10400478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]